Skip to main content

CORRECTION article

Front. Oncol.
Sec. Breast Cancer
Volume 14 - 2024 | doi: 10.3389/fonc.2024.1516633

Corrigendum: Long-term exposure to BAY2416964 reduces proliferation, migration and recapitulates transcriptional changes induced by AHR loss in PyMT-induced mammary tumor cells

Provisionally accepted
  • 1 University of Oslo, Oslo, Norway
  • 2 University of Leeds, Leeds, England, United Kingdom

The final, formatted version of the article will be published soon.

    A corrigendum refers to a change to their article that the author wishes to publish after publication. The publication of this article is subject to Frontiers Editorial approval. Instructions:• please read through all the templates before choosing • pick the most relevant text template(s) from the following page and delete all others.• edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated.In the published article, there was a mistake in the Funding statement. The funding statement for the Key Development Project of the Department of Science and Technology was displayed as "2015CBd051". The correct statement is "Key Development Project of Department of Science and Technology (2015C03Bd051).'' Corrigendum on: Olafsen NE, Das S, Gorrini C and Matthews J ( 2024) Long-term exposure to BAY2416964 reduces proliferation, migration and recapitulates transcriptional changes induced by AHR loss in PyMT-induced mammary tumor cells. Front. Oncol. 14:1466658. doi: 10.3389/fonc.2024.1466658 In the published article, there was an error. The the guide oligo sequences describing the gRNA used to target Ahr were incorrect.A correction has been made to 2 Methods and materials, 2.3 Generation of the PyMT Ahr KO cell line. This sentence previously stated: "Briefly, the guide oligos forward 5´-CCTACGCCAGTCGCAAGCGG-3´ and reverse 5´-CCGCTTGCGACTGGCGTAGG-3´ were annealed and ligated into the pSpCas9(BB)-2A-Puro (PX459) plasmid (Addgene, Watertown, MA, USA; plasmid #62988)."The corrected sentence appears below: "Briefly, the guide oligos forward 5´-AAACTCTAAGCGACACAGAGACCGC-3´ and reverse 5´-CACCGCGGTCTCTGTGTCGCTTAGA-3´ were annealed and ligated into the pSpCas9(BB)-2A-Puro (PX459) plasmid (Addgene, Watertown, MA, USA; plasmid #62988)."The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

    Keywords: Aryl hydrocarbon receptor, BAY2416964, breast cancer, PyMT, GNF351, proliferation, Kynurenine

    Received: 24 Oct 2024; Accepted: 08 Nov 2024.

    Copyright: © 2024 Olafsen, Das, Gorrini and Matthews. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Jason Matthews, University of Oslo, Oslo, Norway

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.